Trupanion Receives a Buy from Canaccord Genuity

Canaccord Genuity analyst Michael Graham reiterated a Buy rating on Trupanion (NYSE: TRUP) yesterday and set a price target of $19. The company’s shares opened today at $14.50.

According to, Graham is a 5-star analyst with an average return of 10.5% and a 59.2% success rate. Graham covers the Technology sector, focusing on stocks such as IAC/InterActiveCorp, Spark Networks Plc, and Angie’s List Inc.

Trupanion has an analyst consensus of Moderate Buy, with a price target consensus of $19.

The company has a one year high of $17.68 and a one year low of $11.15. Currently, Trupanion has an average volume of 83.66K.

Based on the recent corporate insider activity of 45 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider. It provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The company operates its business through two segments: Subscription and Others. The Subscription segment engages in the business of monthly subscriptions of medical plans. The Others segment includes the writing of policies for an unaffiliated managing general agent and policies written under a federal government program. Trupanion was founded by Darryl Rawlings in January 2000 and is headquartered in Seattle, WA.